ANAVEX LIFE SCIENCES CORP. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $16.30 million for the 12-month period ending 2025-09-30, per its 10-K/A filed 2026-08-28.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-08-28
- ANAVEX LIFE SCIENCES CORP. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $16.30M, a 7.24% increase from fiscal 2024.
- ANAVEX LIFE SCIENCES CORP. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $15.20M, a 7.80% increase from fiscal 2023.
- ANAVEX LIFE SCIENCES CORP. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $14.10M, a 327.27% increase from fiscal 2022.
- ANAVEX LIFE SCIENCES CORP. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $3.30M, a 0.00% change from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2025-09-30 | $16.30M 10-K/A · filed 2026-08-28 | |
| 2024-09-30 | $15.20M 10-K/A · filed 2026-08-28 | |
| 2023-09-30 | $14.10M 10-K/A · filed 2026-08-28 | |
| 2022-09-30 | $3.30M 10-K · filed 2022-11-28 | |
| 2021-09-30 | $3.30M 10-K · filed 2024-12-23 | $3.30K 10-K · filed 2021-11-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |